Clonal haematopoiesis and dysregulation of the immune system. Nat Rev Immunol. 2023 Mar 20.
View in:
PubMed
A molecular glue approach to control the half-life of CRISPR-based technologies. bioRxiv. 2023 Mar 20.
View in:
PubMed
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders. bioRxiv. 2023 Feb 15.
View in:
PubMed
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets. Blood. 2023 Jan 18.
View in:
PubMed
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nat Cardiovasc Res. 2023 Jan 16; 2:144-158.
View in:
PubMed
Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Adv. 2022 12 27; 6(24):6151-6161.
View in:
PubMed
Clonal Hematopoiesis and Risk of Incident Lung Cancer. J Clin Oncol. 2023 Mar 01; 41(7):1423-1433.
View in:
PubMed
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood. 2022 11 24; 140(21):2228-2247.
View in:
PubMed
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19. Blood. 2022 11 03; 140(18):1993-1997.
View in:
PubMed
Clonal hematopoiesis transcending species barriers. Blood. 2022 10 20; 140(16):1748-1750.
View in:
PubMed
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms. Blood. 2022 10 20; 140(16):1753-1763.
View in:
PubMed
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. Leukemia. 2022 11; 36(11):2729-2733.
View in:
PubMed
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022 09 22; 140(12):1345-1377.
View in:
PubMed
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022 09 15; 140(11):1200-1228.
View in:
PubMed
A STUB1 ubiquitin ligase/CHIC2 protein complex negatively regulates the IL-3, IL-5, and GM-CSF cytokine receptor common ß chain (CSF2RB) protein stability. J Biol Chem. 2022 10; 298(10):102484.
View in:
PubMed
Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease. Nat Commun. 2022 09 12; 13(1):5350.
View in:
PubMed
TET2-mutant clonal hematopoiesis and risk of gout. Blood. 2022 09 08; 140(10):1094-1103.
View in:
PubMed
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells. J Clin Invest. 2022 08 15; 132(16).
View in:
PubMed
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1621-1629.
View in:
PubMed
Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia. J Intern Med. 2022 08; 292(2):262-277.
View in:
PubMed
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state. Nat Commun. 2022 06 30; 13(1):3778.
View in:
PubMed
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms. Blood Adv. 2022 06 14; 6(11):3201-3206.
View in:
PubMed
Blood's life history traced through genomic scars. Nature. 2022 06; 606(7913):255-256.
View in:
PubMed
Genetics of smoking and risk of clonal hematopoiesis. Sci Rep. 2022 05 04; 12(1):7248.
View in:
PubMed
Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential. Sci Adv. 2022 Apr 08; 8(14):eabl6579.
View in:
PubMed
Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche. Br J Haematol. 2022 07; 198(1):114-130.
View in:
PubMed
Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansion. Blood Adv. 2022 03 22; 6(6):1780-1796.
View in:
PubMed
Leukemia and Heart Disease: Lessons at the Intersection of the Most Feared CHIP Outcomes. JACC CardioOncol. 2022 Mar; 4(1):50-52.
View in:
PubMed
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nat Med. 2022 03; 28(3):468-471.
View in:
PubMed
Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood. 2022 02 24; 139(8):1246-1250.
View in:
PubMed
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022 02 17; 139(7):1098-1110.
View in:
PubMed
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nat Commun. 2022 02 01; 13(1):604.
View in:
PubMed
Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022 01 20; 139(3):357-368.
View in:
PubMed
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Blood Cancer J. 2022 01 11; 12(1):5.
View in:
PubMed
Repurposing the Damage Repair Protein Methyl Guanine Methyl Transferase as a Ligand Inducible Fusion Degron. ACS Chem Biol. 2022 01 21; 17(1):24-31.
View in:
PubMed
Development of PDE6D and CK1a Degraders through Chemical Derivatization of FPFT-2216. J Med Chem. 2022 01 13; 65(1):747-756.
View in:
PubMed
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke. Stroke. 2022 03; 53(3):788-797.
View in:
PubMed
Congenital X-linked neutropenia with myelodysplasia and somatic tetraploidy due to a germline mutation in SEPT6. Am J Hematol. 2022 01 01; 97(1):18-29.
View in:
PubMed
Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J Exp Med. 2021 12 06; 218(12).
View in:
PubMed
Distinction of lymphoid and myeloid clonal hematopoiesis. Nat Med. 2021 11; 27(11):1921-1927.
View in:
PubMed
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events. JAMA Cardiol. 2021 09 01; 6(9):1069-1077.
View in:
PubMed
Systematic Profiling of DNMT3A Variants Reveals Protein Instability Mediated by the DCAF8 E3 Ubiquitin Ligase Adaptor. Cancer Discov. 2022 01; 12(1):220-235.
View in:
PubMed
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy. Blood Adv. 2021 08 10; 5(15):2982-2986.
View in:
PubMed
ZBTB33 is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing. Blood Cancer Discov. 2021 09; 2(5):500-517.
View in:
PubMed
Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure. J Am Coll Cardiol. 2021 07 06; 78(1):42-52.
View in:
PubMed
Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection. Nat Med. 2021 06; 27(6):1012-1024.
View in:
PubMed
Direct Exposure of Welders to Welding Fumes and Effect of Fume Extraction Systems Under Controlled Conditions. J Occup Environ Med. 2021 06 01; 63(6):490-502.
View in:
PubMed
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med. 2021 May; 27(5):927.
View in:
PubMed
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model. Haematologica. 2021 05 01; 106(5):1330-1342.
View in:
PubMed
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. Blood. 2021 04 22; 137(16):2209-2220.
View in:
PubMed
Whole exome sequencing of a breast tumor in a patient with Diamond Blackfan anemia. Blood Cells Mol Dis. 2021 07; 89:102566.
View in:
PubMed
Modeling and targeting of erythroleukemia by hematopoietic genome editing. Blood. 2021 03 25; 137(12):1628-1640.
View in:
PubMed
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature. 2021 04; 592(7853):296-301.
View in:
PubMed
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021 05; 2(3):250-265.
View in:
PubMed
Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide. Nat Rev Clin Oncol. 2021 07; 18(7):401-417.
View in:
PubMed
Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2021 Mar; 591(7851):E27.
View in:
PubMed
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med. 2021 Mar; 27(3):562.
View in:
PubMed
Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML. JCI Insight. 2021 02 08; 6(3).
View in:
PubMed
A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade. Haematologica. 2021 02 01; 106(2):651-654.
View in:
PubMed
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Sci Transl Med. 2021 01 06; 13(575).
View in:
PubMed
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins. Cell Rep. 2021 01 05; 34(1):108532.
View in:
PubMed
Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis. Blood. 2020 12 24; 136(26):3051-3055.
View in:
PubMed
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype. Blood. 2020 12 10; 136(24):2812-2823.
View in:
PubMed
Small-molecule-induced polymerization triggers degradation of BCL6. Nature. 2020 12; 588(7836):164-168.
View in:
PubMed
Hematopoietic mosaic chromosomal alterations and risk for infection among 767,891 individuals without blood cancer. medRxiv. 2020 Nov 16.
View in:
PubMed
Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women. Circulation. 2021 02 02; 143(5):410-423.
View in:
PubMed
Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020 11; 52(11):1219-1226.
View in:
PubMed
Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia. Sci Transl Med. 2020 10 21; 12(566).
View in:
PubMed
Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020 10; 586(7831):763-768.
View in:
PubMed
An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation. Blood Adv. 2020 10 13; 4(19):4679-4692.
View in:
PubMed
Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade. JCO Precis Oncol. 2020; 4.
View in:
PubMed
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med. 2020 10; 26(10):1549-1556.
View in:
PubMed
The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor. JAMA Cardiol. 2020 08 01; 5(8):958-961.
View in:
PubMed
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020 07 09; 136(2):157-170.
View in:
PubMed
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat Commun. 2020 06 12; 11(1):2996.
View in:
PubMed
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature. 2020 09; 585(7824):293-297.
View in:
PubMed
The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020 06; 1(6):565-567.
View in:
PubMed
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia. Cell Rep. 2020 05 26; 31(8):107684.
View in:
PubMed
The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020; 1(6):565-567.
View in:
PubMed
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia. Blood. 2020 05 14; 135(20):1729-1738.
View in:
PubMed
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood. 2020 04 30; 135(18):1548-1559.
View in:
PubMed
Identification of germline variants in adults with hemophagocytic lymphohistiocytosis. Blood Adv. 2020 03 10; 4(5):925-929.
View in:
PubMed
A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis. Eur Heart J. 2020 02 21; 41(8):940-942.
View in:
PubMed
A cryptic imatinib-sensitive G3BP1-PDGFRB rearrangement in a myeloid neoplasm with eosinophilia. Blood Adv. 2020 02 11; 4(3):445-448.
View in:
PubMed
Rapid and deep-scale ubiquitylation profiling for biology and translational research. Nat Commun. 2020 01 17; 11(1):359.
View in:
PubMed
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. Cancer Cell. 2020 01 13; 37(1):104-122.e12.
View in:
PubMed
CHIPing Away at Breast Cancer. J Natl Cancer Inst. 2020 01 01; 112(1):10-11.
View in:
PubMed
Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy. Am J Hematol. 2020 03; 95(3):245-250.
View in:
PubMed
Clonal hematopoiesis as a model for premalignant changes during aging. Exp Hematol. 2020 03; 83:48-56.
View in:
PubMed
Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis. Blood Adv. 2019 11 26; 3(22):3579-3589.
View in:
PubMed
Myelodysplastic syndromes (MDS) occurring in Agent Orange exposed individuals carry a mutational spectrum similar to that of de novo MDS. Leuk Lymphoma. 2020 03; 61(3):728-731.
View in:
PubMed
Clonal hematopoiesis in human aging and disease. Science. 2019 11 01; 366(6465).
View in:
PubMed
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1). Leukemia. 2020 02; 34(2):404-415.
View in:
PubMed
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence. JCO Precis Oncol. 2019; 3.
View in:
PubMed
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science. 2019 08 09; 365(6453):599-604.
View in:
PubMed
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 07 30; 74(4):567-577.
View in:
PubMed
Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation. Blood Adv. 2019 07 23; 3(14):2199-2204.
View in:
PubMed
CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:400-410.
View in:
PubMed
Gene-centric functional dissection of human genetic variation uncovers regulators of hematopoiesis. Elife. 2019 05 09; 8.
View in:
PubMed
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170.
View in:
PubMed
Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background. Blood. 2019 06 13; 133(24):2610-2614.
View in:
PubMed
Intergenerational epigenetic inheritance of cancer susceptibility in mammals. Elife. 2019 04 09; 8.
View in:
PubMed
Genomic subtyping and therapeutic targeting of acute erythroleukemia. Nat Genet. 2019 04; 51(4):694-704.
View in:
PubMed
Impaired human hematopoiesis due to a cryptic intronic GATA1 splicing mutation. J Exp Med. 2019 05 06; 216(5):1050-1060.
View in:
PubMed
Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription. Cell Chem Biol. 2019 05 16; 26(5):711-723.e14.
View in:
PubMed
A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion. Cancer Cell. 2019 02 11; 35(2):283-296.e5.
View in:
PubMed
Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome. Leukemia. 2019 07; 33(7):1759-1772.
View in:
PubMed
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia. 2019 07; 33(7):1747-1758.
View in:
PubMed
CHIPping Away at the Pathogenesis of Heart Failure. JAMA Cardiol. 2019 01 01; 4(1):5-6.
View in:
PubMed
Clonal Hematopoiesis of Indeterminate Potential. J Clin Oncol. 2019 02 10; 37(5):419-422.
View in:
PubMed
Jak-ing Up the Plaque's Lipid Core…and Even More. Circ Res. 2018 11 09; 123(11):1180-1182.
View in:
PubMed
Inhibition of Casein Kinase 1 Alpha in Acute Myeloid Leukemia. N Engl J Med. 2018 11 08; 379(19):1873-1874.
View in:
PubMed
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science. 2018 11 02; 362(6414).
View in:
PubMed
Generations of physician-scientists. J Clin Invest. 2018 10 01; 128(10):4208-4212.
View in:
PubMed
CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk. Circulation. 2018 08 14; 138(7):666-668.
View in:
PubMed
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations. Cancer Cell. 2018 08 13; 34(2):225-241.e8.
View in:
PubMed
Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. Cell Stem Cell. 2018 Aug 02; 23(2):308-309.
View in:
PubMed
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife. 2018 08 01; 7.
View in:
PubMed
CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. Blood. 2018 10 04; 132(14):1535-1544.
View in:
PubMed
Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity. Blood. 2018 09 20; 132(12):1293-1303.
View in:
PubMed
Predicting progression to AML. Nat Med. 2018 07; 24(7):904-906.
View in:
PubMed
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. 2018 09 13; 132(11):1095-1105.
View in:
PubMed
CDK6 Antagonizes p53-Induced Responses during Tumorigenesis. Cancer Discov. 2018 07; 8(7):884-897.
View in:
PubMed
Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers. Ann Intern Med. 2018 07 17; 169(2):116-117.
View in:
PubMed
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. 2018 04 11; 10(436).
View in:
PubMed
Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia. N Engl J Med. 2018 03 29; 378(13):1244-1245.
View in:
PubMed
A decade of progress in myelodysplastic syndrome with chromosome 5q deletion. Leukemia. 2018 07; 32(7):1493-1499.
View in:
PubMed
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities. Haematologica. 2018 04; 103(4):626-633.
View in:
PubMed
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia. Am J Hematol. 2018 02; 93(2):254-261.
View in:
PubMed
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NF?B-dependent differentiation of AML cells. Blood Adv. 2017 Oct 24; 1(23):2046-2057.
View in:
PubMed
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia. Blood. 2017 12 14; 130(24):2631-2641.
View in:
PubMed
Clonal Hematopoiesis and Atherosclerosis. N Engl J Med. 2017 10 05; 377(14):1401-1402.
View in:
PubMed
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017 10 05; 21(4):547-555.e8.
View in:
PubMed
Leukaemia: Vitamin C regulates stem cells and cancer. Nature. 2017 09 28; 549(7673):462-464.
View in:
PubMed
Prevalent premalignancy. Blood. 2017 08 10; 130(6):695-696.
View in:
PubMed
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions. Oncotarget. 2017 Sep 26; 8(43):73483-73500.
View in:
PubMed
Utility of CRISPR/Cas9 systems in hematology research. Exp Hematol. 2017 10; 54:1-3.
View in:
PubMed
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017 07 13; 377(2):111-121.
View in:
PubMed
Introduction to a review series on precision hematology. Blood. 2017 07 27; 130(4):408-409.
View in:
PubMed
NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification. Am J Hematol. 2017 Jul; 92(7):E123-E124.
View in:
PubMed
Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target. Cell Stem Cell. 2017 06 01; 20(6):785-800.e8.
View in:
PubMed
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat Genet. 2017 Jun; 49(6):866-875.
View in:
PubMed
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations. EMBO Mol Med. 2017 04; 9(4):498-507.
View in:
PubMed
Doubling Down on Mutant RAS Can MEK or Break Leukemia. Cell. 2017 02 23; 168(5):749-750.
View in:
PubMed
Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome. J Clin Oncol. 2017 Mar 20; 35(9):968-974.
View in:
PubMed
Introduction to Genomics in Hematologic Malignancy. J Clin Oncol. 2017 03 20; 35(9):927-928.
View in:
PubMed
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation. N Engl J Med. 2017 02 09; 376(6):536-547.
View in:
PubMed
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci Transl Med. 2017 02 08; 9(376).
View in:
PubMed
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability. Elife. 2017 02 08; 6.
View in:
PubMed
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. J Clin Oncol. 2017 May 10; 35(14):1598-1605.
View in:
PubMed
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017 01 26; 129(4):424-447.
View in:
PubMed
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017 01; 17(1):5-19.
View in:
PubMed
Clonal hematopoiesis. Semin Hematol. 2017 01; 54(1):43-50.
View in:
PubMed
The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia. Blood. 2017 01 26; 129(4):497-508.
View in:
PubMed
Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. Cancer Cell. 2016 09 12; 30(3):404-417.
View in:
PubMed
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia. J Clin Invest. 2016 10 03; 126(10):3827-3836.
View in:
PubMed
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 07 11; 30(1):183.
View in:
PubMed
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells. Cancer Cell. 2016 Apr 11; 29(4):602-606.
View in:
PubMed
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586.
View in:
PubMed
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell. 2016 Apr 07; 165(2):303-16.
View in:
PubMed
MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C. J Clin Invest. 2016 Mar 01; 126(3):997-1011.
View in:
PubMed
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9. Nat Med. 2016 Mar; 22(3):288-97.
View in:
PubMed
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells. Cancer Cell. 2016 Feb 08; 29(2):214-28.
View in:
PubMed
An engineered multicomponent bone marrow niche for the recapitulation of hematopoiesis at ectopic transplantation sites. J Hematol Oncol. 2016 Jan 25; 9:4.
View in:
PubMed
Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyond. Curr Opin Cell Biol. 2015 Dec; 37:61-7.
View in:
PubMed
The novel mechanism of lenalidomide activity. Blood. 2015 Nov 19; 126(21):2366-9.
View in:
PubMed
DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples. Clin Chem. 2015 Nov; 61(11):1354-62.
View in:
PubMed
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells. Genome Res. 2015 Dec; 25(12):1860-72.
View in:
PubMed
EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. Blood. 2015 Oct 15; 126(16):1930-9.
View in:
PubMed
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS. Nature. 2015 Jul 09; 523(7559):183-188.
View in:
PubMed
Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea. Blood. 2015 Jun 04; 125(23):3668-9.
View in:
PubMed
Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation. Am J Hematol. 2015 Jul; 90(7):624-8.
View in:
PubMed
Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. Nat Commun. 2015 May 21; 6:7102.
View in:
PubMed
Charting the "Splice" Routes to MDS. Cancer Cell. 2015 May 11; 27(5):607-9.
View in:
PubMed
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015 Jul 02; 126(1):9-16.
View in:
PubMed
Clonal hematopoiesis and blood-cancer risk. N Engl J Med. 2015 03 12; 372(11):1071-2.
View in:
PubMed
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. Cell Rep. 2015 Feb 10; 10(5):755-770.
View in:
PubMed
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015 Feb 26; 125(9):1367-76.
View in:
PubMed
Mutations in G protein ß subunits promote transformation and kinase inhibitor resistance. Nat Med. 2015 Jan; 21(1):71-5.
View in:
PubMed
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014 Dec 25; 371(26):2488-98.
View in:
PubMed
Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell. 2015 Jan 08; 16(1):51-66.
View in:
PubMed
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms. Blood. 2015 Jan 08; 125(2):327-35.
View in:
PubMed
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. Cancer Cell. 2014 Oct 13; 26(4):509-20.
View in:
PubMed
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. Blood. 2014 Oct 23; 124(17):2705-12.
View in:
PubMed
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol. 2014 Dec; 32(12):1262-7.
View in:
PubMed
L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way. Br J Haematol. 2014 Nov; 167(4):524-528.
View in:
PubMed
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. J Clin Oncol. 2014 Sep 01; 32(25):2691-8.
View in:
PubMed
Lenalidomide induces degradation of IKZF1 and IKZF3. Oncoimmunology. 2014; 3(7):e941742.
View in:
PubMed
National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008. Med Care. 2014 Jul; 52(7):612-8.
View in:
PubMed
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat Biotechnol. 2014 Sep; 32(9):941-6.
View in:
PubMed
MDS is a stem cell disorder after all. Cancer Cell. 2014 Jun 16; 25(6):713-4.
View in:
PubMed
Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis. PLoS One. 2014; 9(5):e96209.
View in:
PubMed
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood. 2014 May 29; 123(22):e123-33.
View in:
PubMed
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat Commun. 2014 Mar 24; 5:3469.
View in:
PubMed
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. J Exp Med. 2014 Apr 07; 211(4):605-12.
View in:
PubMed
Musashi-2 controls cell fate, lineage bias, and TGF-ß signaling in HSCs. J Exp Med. 2014 Jan 13; 211(1):71-87.
View in:
PubMed
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014 Jan 03; 343(6166):84-87.
View in:
PubMed
Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science. 2014 Jan 17; 343(6168):301-5.
View in:
PubMed
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nat Chem Biol. 2013 Dec; 9(12):840-848.
View in:
PubMed
Deletion 5q MDS: molecular and therapeutic implications. Best Pract Res Clin Haematol. 2013 Dec; 26(4):365-75.
View in:
PubMed
The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors. Br J Pharmacol. 2013 Oct; 170(4):919-32.
View in:
PubMed
Sinister symbiosis: pathological hematopoietic-stromal interactions in CML. Cell Stem Cell. 2013 Sep 05; 13(3):257-8.
View in:
PubMed
The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders. Leuk Lymphoma. 2014 Mar; 55(3):491-500.
View in:
PubMed
The biology and clinical impact of genetic lesions in myeloid malignancies. Blood. 2013 Nov 28; 122(23):3741-8.
View in:
PubMed
Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndrome. Blood. 2013 Oct 03; 122(14):2487-90.
View in:
PubMed
Toll-like receptor alterations in myelodysplastic syndrome. Leukemia. 2013 Sep; 27(9):1832-40.
View in:
PubMed
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell. 2013 Jul 08; 24(1):45-58.
View in:
PubMed
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes. Leukemia. 2013 Oct; 27(10):2077-81.
View in:
PubMed
Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion. Blood. 2013 May 23; 121(21):4428.
View in:
PubMed
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia. 2013 Nov; 27(11):2177-86.
View in:
PubMed
Macrophages support pathological erythropoiesis in polycythemia vera and ß-thalassemia. Nat Med. 2013 Apr; 19(4):437-45.
View in:
PubMed
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-a in a murine model of polycythemia vera. Blood. 2013 May 02; 121(18):3692-702.
View in:
PubMed
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science. 2013 Mar 29; 339(6127):1621-5.
View in:
PubMed
New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice. Clin Cancer Res. 2013 Apr 01; 19(7):1637-43.
View in:
PubMed
Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U S A. 2012 Nov 27; 109(48):19638-43.
View in:
PubMed
Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Nature. 2012 Nov 22; 491(7425):608-12.
View in:
PubMed
Janus reveals another face: the biologic rationale for targeting Janus kinase 2 in lymphoma. J Clin Oncol. 2012 Nov 20; 30(33):4168-70.
View in:
PubMed
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy. Nature. 2012 Sep 06; 489(7414):155-9.
View in:
PubMed
Molecular pathophysiology of myelodysplastic syndromes. Annu Rev Pathol. 2013 Jan 24; 8:21-47.
View in:
PubMed
Myeloproliferative neoplasm animal models. Hematol Oncol Clin North Am. 2012 Oct; 26(5):1065-81.
View in:
PubMed
miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia. 2013 Feb; 27(2):344-52.
View in:
PubMed
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol. 2012 Sep 20; 30(27):3376-82.
View in:
PubMed
Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. Cell Stem Cell. 2012 Sep 07; 11(3):359-72.
View in:
PubMed
L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood. 2012 Sep 13; 120(11):2214-24.
View in:
PubMed
Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors. Expert Rev Hematol. 2012 Jun; 5(3):303-11.
View in:
PubMed
Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera. Blood. 2012 Jul 05; 120(1):166-72.
View in:
PubMed
Pulmonary fibrosis, bone marrow failure, and telomerase mutation. N Engl J Med. 2012 Apr 19; 366(16):1551-3.
View in:
PubMed
Stress granules contribute to a-globin homeostasis in differentiating erythroid cells. Biochem Biophys Res Commun. 2012 Apr 20; 420(4):768-74.
View in:
PubMed
Mutations in RNA splicing machinery in human cancers. N Engl J Med. 2011 Dec 29; 365(26):2534-5.
View in:
PubMed
Power cut: inhibiting mitochondrial translation to target leukemia. Cancer Cell. 2011 Nov 15; 20(5):555-6.
View in:
PubMed
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms. Blood Cancer J. 2011 Nov; 1(11):e40.
View in:
PubMed
Translational medicine: ribosomopathies. Blood. 2011 Oct 20; 118(16):4300-1.
View in:
PubMed
Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science. 2011 Nov 18; 334(6058):993-6.
View in:
PubMed
Molecular dissection of the 5q deletion in myelodysplastic syndrome. Semin Oncol. 2011 Oct; 38(5):621-6.
View in:
PubMed
Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011 Aug 28; 17(9):1086-93.
View in:
PubMed
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. Blood. 2011 Oct 27; 118(17):4666-73.
View in:
PubMed
Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011 Jun 30; 364(26):2496-506.
View in:
PubMed
Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood. 2011 Aug 25; 118(8):2296-304.
View in:
PubMed
Diamond Blackfan anemia and ribosome biogenesis: introduction. Semin Hematol. 2011 Apr; 48(2):73-4.
View in:
PubMed
Ribosome defects in disorders of erythropoiesis. Int J Hematol. 2011 Feb; 93(2):144-149.
View in:
PubMed
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest. 2011 Feb; 121(2):784-99.
View in:
PubMed
Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011 Jan 21; 144(2):296-309.
View in:
PubMed
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood. 2011 Mar 24; 117(12):3421-9.
View in:
PubMed
Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol. 2011 Feb 10; 29(5):504-15.
View in:
PubMed
STATistical power of clonal analysis: differential STAT1 pathway activation downstream of the JAK2V617F mutation. Cancer Cell. 2010 Nov 16; 18(5):405-6.
View in:
PubMed
Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood. 2011 Mar 03; 117(9):2567-76.
View in:
PubMed
Genetic deletions in AML and MDS. Best Pract Res Clin Haematol. 2010 Dec; 23(4):457-61.
View in:
PubMed
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med. 2010 Oct; 16(10):1147-51.
View in:
PubMed
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med. 2010 Aug; 16(8):903-8.
View in:
PubMed
NF1 inactivation revs up Ras in adult acute myelogenous leukemia. Clin Cancer Res. 2010 Aug 15; 16(16):4074-6.
View in:
PubMed
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A. 2010 Jul 13; 107(28):12617-22.
View in:
PubMed
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell. 2010 Jun 15; 17(6):584-96.
View in:
PubMed
The genetic basis of myelodysplastic syndromes. Hematol Oncol Clin North Am. 2010 Apr; 24(2):295-315.
View in:
PubMed
Preface. The biology and treatment of myelodysplastic syndrome. Hematol Oncol Clin North Am. 2010 Apr; 24(2):xiii-xvi.
View in:
PubMed
The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. Cancer Res. 2010 Apr 15; 70(8):3071-9.
View in:
PubMed
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010 Apr 08; 464(7290):852-7.
View in:
PubMed
The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. Blood. 2010 Apr 29; 115(17):3489-97.
View in:
PubMed
Ribosomopathies: human disorders of ribosome dysfunction. Blood. 2010 Apr 22; 115(16):3196-205.
View in:
PubMed
The landscape of somatic copy-number alteration across human cancers. Nature. 2010 Feb 18; 463(7283):899-905.
View in:
PubMed
Therapeutic potential of targeting haploinsufficient genes in cancer. Pediatr Blood Cancer. 2009 Aug; 53(2):131-2.
View in:
PubMed
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009 Jul 02; 114(1):144-7.
View in:
PubMed
Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer. Leukemia. 2009 Jul; 23(7):1252-6.
View in:
PubMed
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet. 2009 Apr; 41(4):455-9.
View in:
PubMed
Ultrasome: efficient aberration caller for copy number studies of ultra-high resolution. Bioinformatics. 2009 Apr 15; 25(8):1078-9.
View in:
PubMed
Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing. Mol Cell. 2008 Dec 26; 32(6):838-48.
View in:
PubMed
Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases. Mol Cell Endocrinol. 2009 Mar 25; 301(1-2):104-8.
View in:
PubMed
Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells. J Immunol. 2008 Aug 01; 181(3):1859-68.
View in:
PubMed
MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 2008 Jun; 14(6):843-53.
View in:
PubMed
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome. PLoS Med. 2008 Feb; 5(2):e35.
View in:
PubMed
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature. 2008 Jan 17; 451(7176):335-9.
View in:
PubMed
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell. 2007 Dec; 12(6):501-13.
View in:
PubMed
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell. 2007 Oct 12; 28(1):15-27.
View in:
PubMed
Metagene projection for cross-platform, cross-species characterization of global transcriptional states. Proc Natl Acad Sci U S A. 2007 Apr 03; 104(14):5959-64.
View in:
PubMed
Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. EMBO J. 2006 Oct 04; 25(19):4650-62.
View in:
PubMed
Real-time elastography--an advanced method of ultrasound: First results in 108 patients with breast lesions. Ultrasound Obstet Gynecol. 2006 Sep; 28(3):335-40.
View in:
PubMed
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 2006 Jul; 3(7):e270.
View in:
PubMed
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005 Oct 25; 102(43):15545-50.
View in:
PubMed
MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 09; 435(7043):834-8.
View in:
PubMed
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005 Apr; 7(4):387-97.
View in:
PubMed
An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood. 2005 Jun 15; 105(12):4620-6.
View in:
PubMed
Genomic approaches to hematologic malignancies. Blood. 2004 Aug 15; 104(4):923-32.
View in:
PubMed
Hemoglobin variants associated with hemolytic anemia, altered oxygen affinity, and methemoglobinemias. In Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P (ed). Hematology: Basic Principles and Practice. 2004; 645-652.
Pathobiology of the human erythrocyte and its hemoglobins. In Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P (ed). Hematology: Basic Principles and Practice. 2004; 442-454.
Some unusual paraneoplastic syndromes. Case 4. Paraneoplastic nephrotic syndrome in a patient with lung cancer. J Clin Oncol. 2003 Jul 01; 21(13):2624-5.
View in:
PubMed
Time gated fluorescence spectroscopy in Barrett's oesophagus. Gut. 2003 Jan; 52(1):28-33.
View in:
PubMed
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer. Oncologist. 2003; 8(1):69-75.
View in:
PubMed
Bioisosteric determinants for subtype selectivity of ligands for heteromeric GABA(A) receptors. Bioorg Med Chem Lett. 2001 Jun 18; 11(12):1573-7.
View in:
PubMed
Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol. 2001 Apr; 19(4):327-31.
View in:
PubMed
Protoporphyrin IX occurs naturally in colorectal cancers and their metastases. Cancer Res. 2001 Feb 01; 61(3):991-9.
View in:
PubMed
Regulation of the erythropoietin gene. Blood. 1999 Sep 15; 94(6):1864-77.
View in:
PubMed
Synthesis and pharmacology of the baclofen homologues 5-amino-4-(4-chlorophenyl)pentanoic acid and the R- and S-enantiomers of 5-amino-3-(4-chlorophenyl)pentanoic acid. J Med Chem. 1999 Jun 03; 42(11):2053-9.
View in:
PubMed
Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships. J Med Chem. 1998 Jul 02; 41(14):2513-23.
View in:
PubMed
Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol. 1998 Jul; 18(7):4089-96.
View in:
PubMed
Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid. J Med Chem. 1998 Mar 12; 41(6):930-9.
View in:
PubMed
Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships. J Med Chem. 1997 Aug 29; 40(18):2831-42.
View in:
PubMed
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid. J Med Chem. 1997 Feb 14; 40(4):520-7.
View in:
PubMed
Oxygen regulated gene expression: erythropoietin as a model system. Kidney Int. 1997 Feb; 51(2):514-26.
View in:
PubMed
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid. J Med Chem. 1996 Aug 02; 39(16):3188-94.
View in:
PubMed
Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex which recognises mammalian HIF-binding sites. FEBS Lett. 1996 Jun 03; 387(2-3):161-6.
View in:
PubMed
Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists. J Med Chem. 1996 Apr 12; 39(8):1682-91.
View in:
PubMed
Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J. 1996 Feb 01; 313 ( Pt 3):809-14.
View in:
PubMed
N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid. J Med Chem. 1996 Jan 05; 39(1):183-90.
View in:
PubMed
Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem. 1995 Dec 08; 270(49):29083-9.
View in:
PubMed
Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing. Eur J Biochem. 1995 Nov 15; 234(1):92-9.
View in:
PubMed
Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem. 1995 Sep 08; 270(36):21021-7.
View in:
PubMed
Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors. J Med Chem. 1995 Jun 09; 38(12):2188-95.
View in:
PubMed
Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol. 1995 Jun; 268(6 Pt 1):C1362-8.
View in:
PubMed
Regulation of the erythropoietin gene. Nephrol Dial Transplant. 1995; 10 Suppl 2:18-27.
View in:
PubMed
Synthesis and structure-activity studies on acidic amino acids and related diacids as NMDA receptor ligands. J Med Chem. 1994 Sep 30; 37(20):3252-62.
View in:
PubMed
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci U S A. 1994 Jul 05; 91(14):6496-500.
View in:
PubMed
Analysis of cis-acting sequences required for operation of the erythropoietin 3' enhancer in different cell lines. Ann N Y Acad Sci. 1994 Apr 15; 718:31-9; discussion 39-40.
View in:
PubMed
Characterisation of functional domains within the mouse erythropoietin 3' enhancer conveying oxygen-regulated responses in different cell lines. Biochim Biophys Acta. 1994 Apr 06; 1217(3):297-306.
View in:
PubMed
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA]. J Med Chem. 1994 Apr 01; 37(7):878-84.
View in:
PubMed
Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid. J Med Chem. 1992 Sep 18; 35(19):3512-9.
View in:
PubMed
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection. J Med Chem. 1991 Jan; 34(1):123-30.
View in:
PubMed
Study of H2O2-supported N-demethylations catalyzed by cytochrome P-450 and horseradish peroxidase. Biochem Biophys Res Commun. 1983 May 31; 113(1):332-9.
View in:
PubMed
Temperature behaviour of human serum albumin. Eur J Biochem. 1980 Mar; 104(2):469-78.
View in:
PubMed